- 专利标题： NOVEL IMIDAZOPYRIDINES
-
申请号： US13151310申请日： 2011-06-02
-
公开(公告)号： US20110294779A1公开(公告)日： 2011-12-01
- 发明人: DANIELA ALBERATI , RUBÉN ALVAREZ SÁNCHEZ , KONRAD BLEICHER , ALEXANDER FLOHR , KATRIN GROEBKE ZBINDEN , MATTHIAS KOERNER , BERND KUHN , JENS-UWE PETERS , MARKUS RUDOLPH
- 申请人： DANIELA ALBERATI , RUBÉN ALVAREZ SÁNCHEZ , KONRAD BLEICHER , ALEXANDER FLOHR , KATRIN GROEBKE ZBINDEN , MATTHIAS KOERNER , BERND KUHN , JENS-UWE PETERS , MARKUS RUDOLPH
- 优先权： EP09171253.9 20090924
- 主分类号： A61K31/437
- IPC分类号： A61K31/437 ; A61K31/5377 ; C07D519/00 ; A61K31/4985 ; A61K31/553 ; A61P25/22 ; A61K31/541 ; A61P25/18 ; A61P25/28 ; A61P25/24 ; A61P25/30 ; C07D471/04 ; A61K31/496
摘要：
The invention is concerned with novel imidazopyridine derivatives of formula (I) wherein R1, R2, R3, R4, R5 and A are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds inhibit PDE10A and can be used for the treatment of various diseases, including central nervous system disorders such as Alzheimer's disease, Parkinson's disease, and schizophrenia.
公开/授权文献
- US08263584B2 Imidazopyridines 公开/授权日：2012-09-11
信息查询
IPC分类:
